Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.83 USD | +1.02% |
|
-1.00% | +3.41% |
06-13 | Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity | MT |
06-13 | Collegium Pharmaceutical, Inc. Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.41% | 1.04B | |
+54.61% | 811B | |
+44.25% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+18.45% | 246B | |
+2.09% | 225B | |
+13.03% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Insider Trends: Collegium Pharmaceutical Insider Continues 90-Day Selling Trend